We can now offer our patients state-of-the-art office-based solutions which result in excellent outcomes for our patients and provide a great value for the patient, physician, and healthcare system.
Minneapolis, MN (PRWEB) October 07, 2013
Urologix, Inc. (OTCQB:ULGX), the market leader for In-Office BPH Therapy, will host a hands-on workshop at the upcoming 87th Annual Meeting of the North Central Section of the AUA which is being held at the Ritz Carlton in Naples, Florida from October 8-12, 2013. The hands-on workshop will feature advancements in BPH In-Office Therapy and will take place on Wednesday, October 9th from 8:00-4:00 ET in the Plaza III conference room. The session will be led by Dr. J. Randolf Beahrs, a board certified urologist and Director of Minimally Invasive Office Procedures at Metro Urology in St. Paul, Minnesota. Dr. Beahrs has extensive urologic experience and has been very involved with the North Central Section for many years.
“Over my 30 years as a physician, I have seen many breakthroughs and new technologies in Urology. I believe that Urologix’ in-office minimally invasive procedures are certainly another excellent breakthrough for urologists.” stated Dr. Beahrs. “There have been significant improvements in both the technologies as well as the techniques used in these procedures. We can now offer our patients state-of-the-art office-based solutions which result in excellent outcomes for our patients and provide a great value for the patient, physician, and healthcare system.“
This workshop will highlight the advancements of in-office therapy over the past ten years and provide attendees with a unique opportunity to learn about Cooled ThermoTherapy™ and Prostiva® RF Therapy procedures from an experienced physician. Urologists will be able to discuss procedure techniques, review the latest clinical data, and see how the products work up close. Of special interest, Urologix, in collaboration with Dr. Beahrs, will be introducing an educational tool to teach a new technique for performing a periprostatic nerve block which Dr. Beahrs has used extensively to achieve excellent patient comfort with his in-office BPH therapy patients. To find out more about in-office BPH therapies, visit http://www.urologix.com.
For more information or to attend the workshop, participants should stop by the Urologix booth or contact Urologix directly at 888.229.0772 or customerservice(at)urologix(dot)com.
BPH, also known as enlarged prostate, affects the majority of men as they age and can create irritating symptoms which significantly impact quality of life. This disease continues to be predominantly treated with medications; however, research has shown that drugs are not always effective and can produce unpleasant side effects. Cooled ThermoTherapy and Prostiva RF Therapy have proven their results through numerous clinical studies and are recommended treatment options within American Urology Association guidelines.
Visit http://www.urologix.com to learn more about BPH and In-Office BPH Therapy and discover why it is as an excellent alternative to chronic medication therapy.
Urologix, Inc., based in Minneapolis, develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). Urologix’s Cooled ThermoTherapy™ produces targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva® RF Therapy System is an anatomical approach which uses radio frequency energy to destroy the prostate tissue, reducing constriction of the urethra, and thereby relieving BPH symptoms. Both of these therapies provide safe, effective and lasting relief of obstruction and symptoms due to BPH. Prostiva is a registered trademark of Medtronic, Inc., used under license. All other trademarks are the property of Urologix.
Federal USA law restricts these devices to sale by or on the order of a physician. For more complete information about the benefits, risks and contraindications associated with Cooled ThermoTherapy and Prostiva RF Therapy, please refer to http://www.urologix.com.
If you would like more information on this topic, please contact Karen Snay at 513-484-2987 or ksnay(at)urologix(dot)com. To learn more about Urologix and its products and services, visit http://www.urologix.com.
The Urologix logo and other media assets are available at http://www.urologix.com/clinicians/resource-library.php.
Urologix Media Contact
Urologix Investor Relations Contact